Literature DB >> 16871994

Modified double-disc test for detection of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae.

A A Kader1, K K Angamuthu, K A Kamath, M N Zaman.   

Abstract

This study evaluates the performance of a modified double-disc test (MDDT) for the detection of extended-spectrum beta-lactamases (ESBLs) in clinical isolates of Escherichia coli and Klebsiella pneumoniae. Ninety-six isolates of E. coli and 40 K. pneumoniae are studied for ESBL production by the National Committee for Clinical Laboratory Standards (NCCLS) combination disc tests and MDDT A total of 112 (82%) isolates (80 [83%] E. coli, 32 [80%] K. pneumoniae) were positive for ESBL by MDDT compared to 102 (75%; 72 [75%] E. coli and 30 [75%] K. pneumoniae) by the NCCLS method. In 10 (7.4%) isolates, ESBLs were detected only by MDDT Twenty-four (17.6%) isolates were negative for ESBL by both methods. The protocol described in this study provides a more sensitive approach than does the NCCLS method for ESBL detection in E. coli and K. pneumoniae.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16871994     DOI: 10.1080/09674845.2006.11732719

Source DB:  PubMed          Journal:  Br J Biomed Sci        ISSN: 0967-4845            Impact factor:   3.829


  3 in total

1.  Modified Double Disc Synergy Test to Detect ESBL Production in Urinary Isolates of Escherichia coli and Klebsiella pneumoniae.

Authors:  Jaspal Kaur; Shashi Chopra; Gomty Mahajan
Journal:  J Clin Diagn Res       Date:  2013-02-01

2.  Detection of extended spectrum β-lactamase in Pseudomonas spp. isolated from two tertiary care hospitals in Bangladesh.

Authors:  Shahanara Begum; Md Abdus Salam; Kh Faisal Alam; Nurjahan Begum; Pervez Hassan; Jalaluddin Ashraful Haq
Journal:  BMC Res Notes       Date:  2013-01-05

3.  Natural outer membrane permeabilizers boost antibiotic action against irradiated resistant bacteria.

Authors:  Hala A Farrag; Nagwa Abdallah; Mona M K Shehata; Ebthag M Awad
Journal:  J Biomed Sci       Date:  2019-09-09       Impact factor: 8.410

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.